Teneligliptin

• Description:

  Teneligliptin (MP-513) is a novel dipeptidyl peptidase 4 (DPP IV) inhibitor for the treatment of type 2 diabetes mellitus with hypoglycemic activity for the study of obesity and diabetes.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  426.58

• Molecular Formula:

  C22H30N6OS

• Notes:

  Research use only, not for human use.

• Receptor:

  DPP-4

• CAS Number:

  760937-92-6